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Article
Introduction
The diagnosis of ADHD is based mainly on descriptions of 
behaviors that reflect inattention, hyperactivity, and impul-
sivity. Yet older children, adolescents, and adults frequently 
report phenomenological descriptions of internal subjective 
experiences that may underlie the behavioral changes seen in 
ADHD. Characteristic descriptions of the mental state in 
ADHD include reports of ceaseless mental activity, thoughts 
that are constantly on the go, or a mind constantly full of 
thoughts. Thoughts are experienced as uncontrolled, with 
multiple occurring at the same time. Another common 
description is of short-lived thoughts that flit from one thing 
to another, jumping between different ideas (Asherson, 2005; 
Downey, Stelson, Pomerleau, & Giordani, 1997; Weyandt 
et al., 2003). Here, we propose that such excessive mind wan-
dering (MW) may reflect a core difficulty in ADHD that 
underlies some of the experienced impairments.
MW is conceptualized as periods in time when attention 
and the contents of thoughts shift away from external 
sources and/or ongoing tasks to unrelated internal thoughts 
or feelings (Smallwood & Schooler, 2015). It is a universal 
human experience; individuals in the general population are 
estimated to spend between 24% and 50% of their waking 
hours engaging in self-generated thoughts unrelated to their 
external environment (Kane et al., 2007; Killingsworth & 
Gilbert, 2010; Smallwood & Schooler, 2015; Song & Wang, 
2012). Two main types of MW have been identified; first, 
self-generated internal thoughts that occur intentionally/
deliberately, such as planning the menu for a party while 
driving to work. Second, unintentional/spontaneous MW 
when the mind drifts off, for example, during a lecture or 
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Objective: This study investigates excessive mind wandering (MW) in adult ADHD using a new scale: the Mind Excessively 
Wandering Scale (MEWS). Method: Data from two studies of adult ADHD was used in assessing the psychometric 
properties of the MEWS. Case-control differences in MW, the association with ADHD symptoms, and the contribution 
to functional impairment were investigated. Results: The MEWS functioned well as a brief measure of excessive MW 
in adult ADHD, showing good internal consistency (α > .9), and high sensitivity (.9) and specificity (.9) for the ADHD 
diagnosis, comparable with that of existing ADHD symptom rating scales. Elevated levels of MW were found in adults 
with ADHD, which contributed to impairment independently of core ADHD symptom dimensions. Conclusion: Findings 
suggest excessive MW is a common co-occurring feature of adult ADHD that has specific implications for the functional 
impairments experienced. The MEWS has potential utility as a screening tool in clinical practice to assist diagnostic 
assessment. (J. of Att. Dis. XXXX; XX(X)
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conversation. Despite its ubiquitous nature, individuals dif-
fer in the frequency and intentionality of their MW.
Excessive spontaneous MW has been associated with 
functional impairment and implicated in psychopatholo-
gies such as ADHD (Franklin et al., 2014). Mental rest-
lessness, a descriptive term encompassing excessive MW, 
has been reported as more common in ADHD than non-
ADHD individuals (Downey et al., 1997; Weyandt et al., 
2003). Previous work suggests that ADHD is associated 
with spontaneous MW, rather than deliberate MW, and 
detrimental episodes of MW (Franklin et al., 2014; Seli, 
Smallwood, Cheyne, & Smilek, 2015; Shaw & Giambra, 
1993). Detrimental MW has been defined as instances 
when task-unrelated thoughts (TUTs) interfere with task 
performance. In contrast, strategic MW occurs at times 
when TUTs are less likely to interfere with performance 
(whether intentional or not) or when the benefits out-
weigh the costs, and can be an economic use of neuronal 
resources (Franklin et al., 2014; Smallwood & Schooler, 
2015).
Using an experience sampling technique to measure on- 
and off-task thoughts during an attention task, Shaw and 
Giambra (1993) found the frequency of spontaneous (but 
not deliberate) TUTs was increased in college students with 
a childhood history of ADHD compared with controls. 
Furthermore, a sub-clinical group with high levels of ADHD 
symptoms demonstrated more TUTs compared with those 
with low ADHD scores. This finding was subsequently rep-
licated using a rating scale measure of deliberate and sponta-
neous MW in both clinical and non-clinical ADHD samples 
(Seli et al., 2015). In addition, regression analyses revealed 
spontaneous MW to be independently related to ADHD 
symptomatology, whereas deliberate MW was unrelated, 
further suggesting that spontaneous MW is a feature of 
ADHD.
ADHD symptomatology has also been shown to posi-
tively correlate with both the frequency of MW and the lack 
of awareness of engaging in MW (Franklin et al., 2014). A 
sub-clinical group with high ADHD symptom scores had 
disruptive MW episodes even when they were detrimental 
and interfered with function in daily life. In this study, lack-
ing awareness of MW was shown to mediate between 
ADHD symptoms and impairment, suggesting that increas-
ing awareness of MW in ADHD might lead to functional 
improvements.
Collectively, these findings suggest that adults with 
ADHD are highly susceptible to excessive spontaneous MW 
and may have a core difficulty controlling spontaneous 
thoughts unrelated to the current context. Excessive MW 
could therefore underlie many of the symptoms and impair-
ments that characterize the disorder. To explore the role that 
MW may play in the pathogenesis of ADHD, as well as its 
potential role in diagnosis, our research group developed the 
Mind Excessively Wandering Scale (MEWS; see Figure 1). 
The MEWS is a 15-item self-report measure designed to 
reflect MW in ADHD, derived from patient reports of subjec-
tive experiences of their thought processes. The scale cap-
tures the main characteristics of the mental state described by 
adults with ADHD: thoughts on the go all the time, thoughts 
that jump or flit from one topic to another, and multiple lines 
of thoughts at the same time (Asherson, 2005). The MEWS 
therefore reflects the form as opposed to the content of the 
experienced thought processes in ADHD. Uniquely, the 
MEWS assesses a mental phenomenon as opposed to the 
behavioral symptoms conventionally assessed with ADHD 
rating scales.
The aim of the present study was to validate the MEWS 
as an instrument to assess MW in adult ADHD using two 
study samples. In Study 1, we conducted a preliminary 
evaluation of the psychometric properties of the MEWS in 
a small sample of adult males with ADHD selected for the 
absence of comorbid psychiatric conditions. In Study 2, 
we cross-validated the MEWS in a larger independent sam-
ple including males and females, less highly selected 
against comorbidity. We further investigated the relation-
ship of MEWS scores to other measures of ADHD 
Figure 1. Items from the Mind Excessively Wandering Scale 
(MEWS).
Note. Items are scored on a 4-point Likert-type scale (0 = not at all or 
rarely, 1 = some of the time, 2 = most of the time, 3 = nearly all of the time 
or constantly). The MEWS scale is copyrighted and available without 
charge from the corresponding author, and we welcome use of this scale 
in research.
aItems we recommend excluding from the scale in future research, based 
on analysis conducted here.
Item:
 1. I have difficulty controlling my thoughts
 2. I find it hard to switch my thoughts off
 3. I have two or more different thoughts going on at the same time
 4. My thoughts are disorganised and ‘all over the place’
 5. My thoughts are ‘on the go’ all the time
 6. a Because my mind is ‘on the go’ at bedtime, I have difficulty 
falling off to sleep
 7. I experience ceaseless mental activity
 8. I find it difficult to think about one thing without another 
thought entering my mind
 9. I find my thoughts are distracting and prevent me from 
focusing on what I am doing
10. a I try to distract myself from my thoughts by doing something 
else or listening to music
11. I have difficulty slowing my thoughts down and focusing on 
one thing at a time
12. I find it difficult to think clearly, as if my mind is in a fog
13. I find myself flitting back and forth between different thoughts
14. a I use alcohol or other drugs to slow down my thoughts and 
stop constant ‘mental chatter’
15 I can only focus my thoughts on one thing at a time with 
considerable effort
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symptomatology, and investigated the relationship between 
MW and functional impairment.
Method
Study 1 Sample
Participants were a small subset of adults from the MIRIAD 
(Mood Instability Research in ADHD) project, a longitudi-
nal case-control study of emotional lability (EL) and neuro-
psychological functioning in adult men with ADHD with no 
co-occurring comorbidities (Skirrow & Asherson, 2013). 
Forty-one adults with ADHD and 47 controls aged between 
18 and 65 years (ADHD: M = 28.54 years, SD = 9.52 years; 
control: M = 29.00 years, SD = 10.46 years) participated in 
the MIRIAD project. There were no significant differences 
between groups for age or IQ (see Table 1). ADHD partici-
pants were recruited from the waiting list of the National 
Adult ADHD Clinic at the South London and Maudsley 
Hospital (SLaM) and were medication free at the time of 
the research assessment. Further detail on the recruitment 
process is provided elsewhere (Skirrow & Asherson, 2013).
As the MEWS was developed after the MIRIAD project 
began, only a subset of the ADHD cases and controls pro-
vided MEWS data. At study entry (baseline), 25 cases and 
24 controls completed the MEWS. Follow-up assessments 
completed approximately 9 months after baseline provided 
data on 18 cases and 18 controls at both time points. In 
addition, six cases and 18 controls provided MEWS data at 
follow-up assessment alone. Of the 18 ADHD cases with 
data at both time points, 16 were treated with methylpheni-
date and one with atomoxetine at follow-up, initiated by 
local services and not following a specific protocol. Ethical 
approval for this study was obtained from the Joint Research 
Ethics Committee of the Institute of Psychiatry and SLaM.
Study 2 Sample
Participants were from the OCEAN (Oils and Cognitive 
Effects in Adult ADHD Neurodevelopment) project, a study 
investigating the relationship of omega-3 dietary supple-
mentation (not analyzed in this study) to cognitive and elec-
trophysiological measures in adults with ADHD. Participants 
were aged between 18 and 65 years. The sample consisted of 
81 adults with ADHD (37 female, 44 male; M age = 33.52 
years, SD = 10.26 years) and 30 healthy controls (14 female, 
16 male; M age = 29.51 years, SD = 8.8 years). Groups did 
not significantly differ on age, sex, or IQ (see Table 1). 
ADHD participants were recruited through SLaM Adult 
ADHD Service, advertisements on ADHD support websites, 
and previous study databases. See online supplementary 
material for further information on recruitment.
At baseline (Time 1), 79 cases and 29 controls provided 
MEWS data. Two separate follow-up assessments of the 
ADHD cases took place, 3 months (Time 2) and 6 months 
(Time 3) after baseline. At Time 2 and Time 3, 79 and 55 
ADHD cases provided MEWS data, respectively. Ethical 
approval for the study was granted by the National Research 
Ethics Service (NRES) Committee London.
Measures
ADHD symptoms. ADHD symptoms were assessed using 
the self-rated Barkley Adult ADHD Rating Scale (BRS; 
Barkley, 1998) in Study 1, and the Conners’ Adult ADHD 
Rating Scales (CAARS; Conners, Erhardt, & Sparrow, 
1999) in Study 2. Both scales cover the same list of 18 
DSM-IV/DSM-5 items for inattention and hyperactivity 
(Diagnostic and Statistical Manual of Mental Disorders 
(4th ed. and 5th ed.; American Psychiatric Association 
[APA], 1994 and 2013).
Table 1. Case-Control Differences for Age, Sex, IQ, MEWS, INN, HI, EL, and IMP.
Study 1 Study 2
 ADHD Control
p
ADHD Control
p N M SD N M SD N M SD N M SD
Age 41 28.54 9.52 47 29.00 10.46 .83 81 33.52 10.26 30 29.51 8.80 .06
Male 41 47 — 44 16 .93
Female 0 0 37 14  
IQ 41 108.95 15.08 47 113.15 13.36 .17 80 109.38 13.68 23 111.59 11.62 .44
Time 1
 MEWS 25 25.00 10.11 24 4.79 6.98 <.0001 79 27.72 9.31 29 7.21 6.26 <.0001
 INN 41 19.34 5.03 47 3.87 3.44 <.0001 81 27.16 6.13 30 6.23 3.99 <.0001
 HI 40 16.20 6.59 47 3.28 3.30 <.0001 81 20.09 5.80 30 5.33 4.08 <.0001
 EL 40 45.93 11.76 46 25.24 9.17 <.0001 80 24.31 12.09 30 4.17 4.86 <.0001
 IMP 41 1.23 0.41 47 0.30 0.28 <.0001 80 1.22 0.49 30 0.20 0.20 <.0001
Note. See Online Supplementary Table 1 for Time 2 and Time 3. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/
impulsivity; EL = emotional lability; IMP = impairment.
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Emotional dysregulation. Emotional Lability (EL) was mea-
sured using the Affective Lability Scale–Short Form (ALS-
SF; Oliver & Simons, 2004), which measures rapid changes 
in emotional states.
Impairment. Functional impairment across major life 
domains (family, work, school, life-skills, self-concept, 
social, and risk) was measured using the Weiss Functional 
Impairment Rating Scale–Self-Report (WFIRS-S; Sadek, 
2014).
Mind wandering. MW was measured using the newly cre-
ated MEWS (see Figure 1). This publication is the first 
report of this scale. The MEWS is a 15-item self-report 
measure reflecting MW in ADHD. Items were based on 
patient descriptions of MW in ADHD as previously 
described by Asherson (2005). P.A., C.S., and P.R. drew up 
the list of questions based heavily on their combined experi-
ence of patient’s reports of MW, and questions were refined 
during several consensus meetings. The final item checklist 
was agreed by all three authors and implemented initially in 
the MIRIAD study before further testing in the OCEAN 
study (reported here). The MEWS scale is copyrighted and 
available without charge from the corresponding author.
Statistical Analyses
Mean values for each rating scale and subscale were used as 
summary measures. The raw data and square-root transfor-
mations were used in analysis, and parametric and non-
parametric tests were used as appropriate.
Principal components analysis (PCA) with varimax rota-
tion was conducted to examine the factor structure of the 
MEWS. Cronbach’s alpha was used as a measure of reli-
ability to assess internal consistency and Pearson’s correla-
tion coefficient was used to analyze test–retest reliability of 
the scale. Construct validity was assessed with independent 
t tests and Mann–Whitney U tests to investigate case- 
control differences. Receiver operating characteristic 
(ROC) analysis was used to examine diagnostic accuracy 
and the optimal cut-off point of the measure.
Convergent validity of the MEWS in relation to ADHD 
symptom scales was assessed using polyserial correlations 
to provide unbiased estimates of cross-variable correlations 
in case-control samples (Olsson, 1979). For these analyses, 
we fixed the z value threshold for affection status corre-
sponding to 3.4% prevalence of ADHD in adults (Fayyad 
et al., 2007). In Study 1, polyserial correlations were also 
conducted on change scores (Time 1-Time 2). For change 
scores in Study 2, we used partial correlations to control for 
potential influences of the study intervention (placebo or 
essential fatty acid). Hierarchical multiple regression was 
used to investigate whether MEWS scores were independent 
predictors of impairment; inattention and hyperactivity/
impulsivity were entered in the first step and MW in the 
second.
Results
Study 1
Psychometric evaluation. The scree plot and eigenvalues 
indicated a unidimensional structure to the MEWS with one 
factor accounting for 69.16% of the variance (eigenvalue = 
10.37; see online supplementary material). Factor loadings 
were greater than .7, with the exception of Item 14 (.51). 
Table 2 shows Cronbach’s alpha coefficients for the full 
15-item MEWS in comparison with the other rating scales. 
At baseline, internal consistency was high for all scales for 
both cases and controls (α > .78). Examination of item total 
correlations showed each item to correlate well with the full 
15-item scale (correlations > .75, with the exception of 
Items 6 [.66], 10 [.70], and 14 [.47]), suggesting items are 
measuring the same underlying construct. Inter-item corre-
lations ranged from .27 to .88, with an average inter-item 
correlation of .66, reflecting the internal consistency of the 
scale items.
There was a mean interval of 9.7 months (SD = 3.3 
months) for cases and 9.5 months (SD = 4.0 months) for 
controls between baseline and follow-up. Test–retest reli-
ability was significant for the whole sample (r = .84, 95% 
confidence interval [CI] = [.74, .92], p < .001), and for both 
cases (r = .63, 95% CI = [.06, .88], p = .005) and controls 
(r = .82, 95% CI = [.40, .93], p < .001).
Construct validity. Case-control comparisons at baseline 
revealed significantly elevated ratings of MW in individu-
als with ADHD, t(47) = −7.83, p < .0001, comparable with 
that found for the other rating scales of ADHD symptom 
domains: inattention, t(73.07) = −14.58, p < .0001; hyper-
activity/impulsivity, t(85) = −11.40, p < .0001; emotional 
lability, U = 168.5, z = −6.53, p < .0001 (Table 1). Partici-
pants with ADHD also demonstrated significantly greater 
overall impairment on the WFIRS-S, t(86) = −13.08, p < 
.0001, as well as for each domain of impairment, t range = 
−5.78-11.40, p < .0001, for impairment in family life, work, 
school, life-skills, self-concept, social problems, and risk 
taking. Similar results were found at follow-up (see online 
supplementary material).
ROC analysis was used to examine the capacity of the 
scale to discriminate between cases and controls. Area 
under the curve (AUC) was .92 (95% CI = [.85, 1.00], p < 
.0001) which, being close to 1, indicates excellent discrimi-
nant capacity of the MEWS. This was comparable with the 
AUC value of existing rating scales of ADHD symptom 
domains (inattention: AUC = .99, 95% CI = [.97, 1.00]; 
hyperactivity/impulsivity: AUC = .95, 95% CI = [.91, .99]; 
emotional lability: AUC = .91, 95% CI = [.84, .97]). A score 
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of 15 or above provides the optimal balance of sensitivity 
(.88) and specificity (.88), suggesting a cut-off for disorder 
threshold (see online supplementary material).
Convergent validity. Polyserial correlations in the combined 
case-control data set showed strong positive correlations 
between MW and the other rating scales of ADHD and 
impairment: inattention (r = .81, 95% CI = [.72, .87]), 
hyperactivity/impulsivity (r = .77, 95% CI = [.66, .84]), 
emotional lability (r = .81, 95% CI = [.72, .88]), and impair-
ment (r = .82, 95% CI = [.71, .89]), as well as ADHD 
affection status (r = .70, 95% CI = [.57, .79]). The strongest 
correlation was between MW and impairment (Table 3). In 
addition, moderate to large positive correlations were seen 
between MW and ADHD symptom dimensions and impair-
ment in both cases and controls analyzed separately (see 
online supplementary material), indicating severity of 
symptoms and impairment in both cases and controls.
For the sub-sample with both baseline and follow-up 
data, the correlation of baseline to follow-up change scores 
for MW with change scores for the rating scale measures of 
ADHD symptoms and impairments revealed temporal 
Table 3. Polyserial Correlations (95% Confidence Intervals), Corrected for Selection (Affection Threshold = 3.4%), Between the 
MEWS, INN, HI, EL, and IMP Rating Scales, and AFF.
Time 1 MEWS INN HI EL IMP
Study 1
 MEWS — — — — —
 INN .81 [.72, .87] — — — —
 HI .77 [.66, .84] .85 [.79, .89] — — —
 EL .81 [.72, .88] .74 [.65, .81] .75 [.64, .81] — —
 IMP .82 [.71, .89] .83 [.76, .88] .82 [.75, .87] .77 [.68, .83] —
 AFF .70 [.57, .79] .83 [.75, .89] .71 [.60, .79] .65 [.51, .75] .75 [.64, .83]
Study 2
 MEWS — — — — —
 INN .77 [.69, .83] — — — —
 HI .69 [.58, .76] .76 [.68, .82] — — —
 EL .74 [.66, .81] .62 [.50, .71] .53 [.40, .65] — —
 IMP .81 [.74, .086] .74 [.65, .80] .65 [.54, .73] .78 [.70, .83] —
 AFF .67 [.55, .77] .83 [.76, .88] .74 [.64, .81] .59 [.46, .70] .68 [.57, .78]
Note. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = impairment;  
AFF = affection status.
Table 2. Reliability Coefficients (α) for the MEWS as Compared With the INN, HI, EL, and IMP Rating Scales.
Study 1
Time 1 Time 2
Whole sample Cases Controls Whole sample Cases Controls
MEWS .97 .93 .95 .96 .94 .93
INN .96 .83 .80 .96 .92 .82
HI .95 .88 .78 .92 .88 .76
EL .96 .91 .95 .96 .91 .96
IMP .98 .96 .96 .97 .88 .98
Study 2
Time 1 Time 2 Time 3
Whole sample Cases Controls Cases Cases
MEWS .96 .91 .90 .94 .95
INN .96 .85 .82 .91 .98
HI .93 .83 .75 .87 .99
EL .95 .92 .87 .91 .93
IMP .98 .98 .86 .98 .97
Note. MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity; EL = emotional lability; IMP = impairment.
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covariance between the measures: positive correlations 
were found between change in MW and change in inatten-
tion (r = .72, 95% CI = [.54, .83]), hyperactivity/impulsivity 
(r = .55, 95% CI = [.33, .70]), emotional lability (r = .70, 
95% CI = [.44, .84]), and impairment (r = .51, 95% CI = 
[.23, .72]; see Table 4). In the 16 cases treated with methyl-
phenidate at follow-up, there was a significant reduction in 
MEWS scores, t(15) = 2.28, p = .04, between the baseline 
medication-free period (M = 23.38, SD = 10.93) and follow-
up (M = 17.25, SD = 10.58).
Impairment. Data from 49 participants were used in regres-
sion analyses with the WFIRS-S total impairment score. 
Inattention and hyperactivity/impulsivity accounted for 
82.4% of the variability in functional impairment (R2 = 
.824). The addition of MW as a predictor led to a significant 
increase in predictive power of the model (R2Δ = .024), with 
the variability accounted for by the model increasing to 
84.9%, FΔ(1, 45) = 7.17, p = .01. This indicates that MW is 
having a small but significant effect beyond that accounted 
for by inattention and hyperactivity/impulsivity. Inattention 
carried the most importance in the model (β = .45), fol-
lowed by MW (β = .31) and hyperactivity/impulsivity (β = 
.21). Only inattention and MW significantly contributed to 
the model (p = .001 and .01, respectively).
Within the ADHD group, MW had an independent effect 
on impairment in the domains of self-concept, R2Δ = .145, 
FΔ(1, 21) = 6.57, p < .02, and social problems, R2Δ = .137, 
FΔ(1, 21) = 4.50, p < .05. For the social problems domain, 
MW carried more importance in the model (β = .44) than 
inattention (β = −.42), but not hyperactivity/impulsivity (β = 
.50). Only MW and hyperactivity/impulsivity significantly 
contributed to the model (p = .05 and .03, respectively). 
Interpretation of work and life-skills dimensions was not 
possible due to heteroskedasticity in the data.
Study 2
Psychometric evaluation. The scree plot and eigenvalues sug-
gested a one-factor solution with an eigenvalue of 9.44, 
accounting for 62.92% of the variance (see online supple-
mentary material). All items loaded highly onto this factor 
(>.76, with the exception of Items 6 [.60], 10 [.68], and 14 
[.40]). Internal consistency was high for all scales for both 
cases and controls (α > .78; see Table 2). Examination of item 
total correlations showed each item to correlate well with the 
full 15-item scale (correlations > .72, with the exception of 
Items 6 [.56], 10 [.63], and 14 [.37]). Inter-item correlations 
ranged from .24 to .82, with an average inter-item correlation 
of .59, reflecting the internal consistency of the scale items.
The mean interval between Time 1 and Time 3 was 6.4 
months (SD = 0.58 months), and MEWS scores showed sat-
isfactory retest reliability across this time period (r = .63, 
95% CI = [.42, .80], p < .0001).
Construct validity. Case-control comparisons revealed sig-
nificantly elevated ratings of MW in individuals with 
ADHD (U = 87.00, z = −7.34, p < .0001). This difference 
was comparable with that found for the other rating scales 
of ADHD symptom domains (inattention: U = 20.00, z = 
−7.94, p < .0001; hyperactivity/impulsivity: U = 64.50, z = 
−7.65, p < .0001; emotional lability: U = 140.50, z = −7.12, 
p < .0001; see Table 1). ADHD cases also demonstrated sig-
nificantly greater overall impairment on the WFIRS-S (U = 
53.50, z = −7.70, p < .0001), as well as for each domain of 
impairment (z range = −4.87 to −7.57, p < .0001 for impair-
ment in family life, work, school, self-concept, social prob-
lems, life-skills, and risk taking; see online supplementary 
material).
ROC curve analysis indicated that the MEWS success-
fully discriminated between cases and controls (AUC = .96, 
Table 4. Correlations (95% Confidence Intervals) Between Change Scores for the MEWS, INN, HI, EL, and IMP Rating Scales.
Change scores MEWS INN HI EL
Study 1
 MEWS — — — —
 INN .72 [.54, .83] — — —
 HI .55 [.33, .70] .73 [.59, .82] — —
 EL .70 [.44, .84] .55 [.35, .70] .58 [.39, .72] —
 IMP .51 [.23, .72] .62 [.45, .74] .62 [.45, .74] .55 [.35, .70]
Study 2
 MEWS — — — —
 INN .53 [.25, .71]**** — — —
 HI .31 [.01, .52]* .74 [.53, .86]**** — —
 EL .43 [.19, .62]*** .48 [.16, .71]**** .31 [−.03, .59]* —
 IMP .62 [.37, .78]**** .50 [.31, .66]**** .41 [.18, .59]** .44 [.18, .65]***
Note. Polyserial correlations corrected for selection (affection threshold = 3.4%) were used in Study 1, and partial correlations to correct for study 
intervention in Study 2 (with significance levels). MEWS = Mind Excessively Wandering Scale; INN = inattention; HI = hyperactivity/impulsivity;  
EL = emotional lability; IMP = impairment.
*p < .03. **p < .01. ***p = .001. ****p < .0001.
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95% CI = [.93, .99], p < .0001). This was comparable with 
the AUC value of existing rating scales of ADHD symptom 
domains (inattention: AUC = .99, 95% CI = [.98, 1.00]; 
hyperactivity/impulsivity: AUC = .97, 95% CI = [.95, 1.00]; 
emotional lability: AUC = .94, 95% CI= [.90, .98]). A score 
of 15 on the MEWS provides the optimal balance of sensi-
tivity (.90) and specificity (.90; see online supplementary 
material).
Convergent validity. Using polyserial correlations in the 
combined case-control data set, we found a positive correla-
tion between MW and the other rating scales of ADHD and 
impairment: inattention (r = .77, 95% CI = [.69, .83]), 
hyperactivity/impulsivity (r = .69, 95% CI = [.58, .76]), 
emotional lability (r = .74, 95% CI = [.66, .81]), impairment 
(r = .81, 95% CI = [.74, .86]), and ADHD affection status 
(r = .67, 95% CI = [.55, .77]). The strongest correlation was 
between MW and impairment (see Table 3). Moderate to 
large positive correlations were also seen between MW and 
ADHD symptom dimensions and impairment in both cases 
and controls analyzed separately (see online supplementary 
material).
Investigation of change scores also revealed a temporal 
relationship. Analyses indicated significant covariation of 
change in MW with change in inattention (r = .53, 95% CI 
= [.25, .71], p < .0001), hyperactivity/impulsivity (r = .31, 
95% CI = [.01, .52], p = .02), emotional lability (r = .43, 
95% CI = [.19, .62], p = .001), and impairment 
(r = .62, 95% CI = [.37, .78], p < .0001). MW and impair-
ment showed the strongest relationship (see Table 4).
Impairment. Data from 108 participants were used in regres-
sion analysis with the WFIRS-S total impairment score. 
Inattention and hyperactivity/impulsivity accounted for 
71.3% of the variability in functional impairment (R2 = 
.713). The addition of MW as a predictor led to a significant 
increase in predictive power of the model (R2Δ = .076), with 
the variability accounted for by the model increasing to 
78.9%, FΔ(1, 104) = 37.17, p < .0001. MW carried the most 
importance in the model (β = .49), followed by inattention 
(β = .29) and hyperactivity/impulsivity (β = .17). Only MW 
(p < .0001) and inattention (p = .002) significantly contrib-
uted to the model.
Within the ADHD group, MW had an independent effect 
on impairment in life-skills, R2Δ = .18, FΔ(1, 75) = 24.79, 
p < .0001; self-concept, R2Δ = .10, FΔ(1, 75) = 9.72, p = 
.003; social problems, R2Δ = .10, FΔ(1, 75) = 9.92, p = .002; 
and risk taking, R2Δ = .09, FΔ(1, 75) = 9.37, p = .003. MW 
carried the most importance in the model for life-skills (β = 
.52), self-concept (β = .39), and social problems (β = .39), 
and was the only significant contributor to the model for the 
self-concept (p = .003) and social problems (p = .002) 
domains. Interpretation of the family and work domains 
was not possible due to heteroskedasticity in the data.
Discussion
We report the psychometric properties and initial validation 
findings for a new self-report scale of excessive MW in 
adults with ADHD. Using two independent samples, we 
found that MEWS scores functioned extremely well as a 
measure of the mental phenomenon of MW in ADHD, with 
good reliability and high sensitivity and specificity for 
ADHD case-control differences. We found that elevated 
levels of MW (as indexed by the MEWS) in participants 
with ADHD were related to self-report measures of func-
tional impairment. Furthermore, the contribution of MW to 
impairment was independent of the core ADHD symptoms 
of inattention and hyperactivity/impulsivity. These findings 
suggest that excessive MW is a characteristic feature of 
adult ADHD that has specific effects on impairment.
Principal components analysis indicated a unidimen-
sional structure to the scale and other psychometric proper-
ties of the MEWS were comparable with existing rating 
scales of ADHD core symptoms, including good internal 
consistency and test–retest reliability. The MEWS was able 
to differentiate between those with and without ADHD with 
high sensitivity and specificity of the scale, using a thresh-
old score of 15. This is remarkable given that patients were 
selected for high ADHD symptoms and not specifically for 
subjective reports of internal thought processes as measured 
by the MEWS.
In both studies, item total correlations with the full 
15-item scale and factor loadings were high apart from 
Items 6 (Because my mind is “on the go” at bedtime, I have 
difficulty falling off to sleep), 10 (I try to distract myself 
from my thoughts by doing something else or listening to 
music), and 14 (I use alcohol or other drugs to slow down 
my thoughts and stop constant “mental chatter”). This is 
likely explained by the nature of these items, which refer to 
how individuals cope with MW or how it directly affects 
their functioning, as opposed to a description of the mental 
phenomenon. To investigate whether the scale could be 
shortened by dropping Items 6, 10, and 14 without reducing 
its sensitivity and specificity, we repeated the ROC analy-
sis, finding the shorter 12-item scale had a sensitivity of .89 
and specificity of .90 (see online supplementary material). 
Further analyses in larger data sets could be used to further 
refine the scale, but based on these data we recommend that 
future studies use the reduced 12-item scale.
Our findings are in line with previous studies which 
report elevated levels of MW in ADHD compared with con-
trols, whether measured using clinical rating scales 
(Franklin et al., 2014; Seli et al., 2015; Weyandt et al., 2003) 
or experience sampling of TUTs during a sustained atten-
tion task (Shaw & Giambra, 1993). Furthermore, the 
strength of case-control differences for MEWS scores was 
comparable with that seen for rating scale measures of core 
ADHD symptoms, for which clinical cases of ADHD are 
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selected on. MEWS scores were also found to be highly 
correlated with ADHD symptoms and impairment in the 
total sample, as well as in cases and controls analyzed sepa-
rately, replicating previous studies of the association 
between spontaneous MW and ADHD (Franklin et al., 
2014; Seli et al., 2015). These results indicate that the 
MEWS is a marker of symptom severity in both cases and 
controls, in line with previous data indicating that ADHD 
symptoms lie along a continuum in the general population 
(Chen et al., 2008; Salum et al., 2014).
Change scores for MW also covaried with ADHD symp-
toms and impairments over time, indicating a close tempo-
ral relationship consistent with a potential causal role of 
MW in ADHD. The finding of significant pre–post treat-
ment effects of methylphenidate in a subset of Study 1 par-
ticipants raises the possibility that treatment effects on 
ADHD might be mediated by reductions in MW. However, 
we were unable to test specifically for treatment effects of 
methylphenidate because we did not randomize to treat-
ment or include a placebo control arm.
The link between MW and impairment was particularly 
strong, indicating the clinical importance of MW in adults 
with ADHD. Of specific interest was the finding that MW 
showed a main effect on impairment beyond the influence 
of inattention and hyperactivity/impulsivity and was overall 
the strongest predictor of impairment in Study 2. 
Investigating specific domains of impairment, MW was 
found to be an independent predictor of self-concept and 
social problems in both studies, and additionally life-skills 
and risk taking in Study 2. The reasons the MEWS is a par-
ticularly good predictor of impairment in ADHD are not 
well understood, but could be explained by both clinical 
and theoretical considerations. One possible explanation is 
that the scale items are rooted in qualitative accounts from 
adult ADHD patients of experiences of their mental state. 
When asked to describe the subjective experience of the 
flow of their thoughts, adults with ADHD repeatedly give 
descriptions of ceaseless, short-lived, and unfocused 
thoughts that flit from one topic to another (Asherson, 
2005). Such a distractible and poorly regulated mental state 
could be impairing for several reasons.
First, excessive MW may have a specific effect on func-
tional outcomes due to the failure to deal with distraction 
and deficient mental processing of “task”relevant events. In 
social situations, an individual with excessive MW may 
miss verbal and non-verbal information and effectively not 
listen or lack awareness of social cues. MW may make it 
difficult to follow a single line of thought and interrupting 
others during conversations could be a strategy to avoid los-
ing their train of thought. Behaviors such as these are likely 
to have negative effects on an individual’s social 
interactions.
Second, lack of attention paid to events due to one’s 
mind constantly being “on the go” in a non-focused way 
can also create difficulties with thinking through and plan-
ning activities, linked to forgetfulness and disorganization 
and leading to impairments in basic life-skills. Impaired 
self-concept may then arise as a bi-product of the effect of 
excessive MW on other domains of functioning, but could 
also be due to distress from the constant effort to focus or 
the experience of having a mind constantly full of unfo-
cused distractible thoughts. Many patients report a sense of 
calm and relief when the flow of their thoughts becomes 
more focused and regulated following stimulants or other 
treatments for ADHD.
Third, the connection between MW and risk-taking 
behavior is less obvious, but could be due to the impact of 
highly salient activities, which engage the attention of indi-
viduals, leading to a reduction of spontaneous MW and a 
sense of relief. For the same reasons, some patients with 
even severe levels of ADHD may excel at activities such as 
exciting/stimulating sports. Although there is as yet no 
direct evidence for this hypothesis, studies investigating 
default mode deactivation (Liddle et al., 2011) and reaction 
time variability (RTV; Andreou et al., 2007) during tasks 
requiring sustained attention have shown reduced or absent 
case-control differences when conducted under highly 
salient conditions. Reductions in default mode activity 
under rewarding conditions have been hypothesized to 
reflect reductions in excessive MW (Liddle et al., 2011). 
Thus, risky behavior may reflect individuals seeking out 
activities with salient content, which decreases MW and 
helps individuals with ADHD to focus their attention.
These accounts of MW leading to impairment in ADHD 
remain speculative because of the lack of research on MW 
in ADHD. However, an increase in understanding of MW 
states in control participants provides a strong theoretical 
basis for the hypothesis that excessive MW may underlie 
many of the behavioral symptoms and impairments seen in 
ADHD. In healthy control samples, MW is associated with 
performance deficits that overlap with impairments seen in 
ADHD, including educational performance, driving acci-
dents, and performance on cognitive tasks including errors 
of commission and RTV during sustained attention and 
inhibition tasks (Smallwood & Schooler, 2015). 
Understanding of the neural processes involved in the regu-
lation of internal thought, involving default mode network 
(DMN) and executive control networks, has advanced in 
recent years, and overlaps with neural mechanisms impli-
cated in ADHD. TUTs are strongly associated with defi-
cient task-induced deactivation of the DMN (correlation 
about .9; McKiernan, D’Angelo, Kaufman, & Binder, 
2006), and deficient DMN deactivation during task condi-
tions is strongly associated with ADHD (Christakou et al., 
2013). Spontaneous MW that is detrimental to performance 
has, therefore, been proposed as a mechanism that explains 
many of the symptoms and functional impairments of 
ADHD (Seli et al., 2015; Weyandt et al., 2003), reflecting 
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aberrant inter-relationships between default and task posi-
tive networks (Fox, Spreng, Ellamil, Andrews-Hanna, & 
Christoff, 2015; Sripada, Kessler, & Angstadt, 2014).
Interestingly, in one study, meta-awareness of MW (being 
aware that your mind has wandered) was found to mediate 
the relationship between ADHD symptoms and detrimental 
forms of MW, suggesting that psychological treatments 
aimed at enhancing meta-awareness of MW, such as mind-
fulness-based interventions (MBIs), might ameliorate the 
negative consequences of MW in ADHD (Franklin et al., 
2014). Recent studies support the beneficial effects of MBIs 
on ADHD, with the largest study to date showing an effect of 
d = .85 on ADHD symptoms compared with a treatment as 
usual group (Hepark et al., 2015). Future large-scale con-
trolled experimental designs are therefore indicated to inves-
tigate the potential role of MW as a treatment target for the 
control of ADHD symptoms and impairments using both 
pharmacological and non-pharmacological interventions.
Current screening tools for adult ADHD consist of rating 
scales for inattention and hyperactivity/impulsivity. Our 
findings suggest potential utility of the MEWS as an addi-
tional screening tool for adult ADHD in clinical practice, 
particularly as the MEWS is a strong predictor of impair-
ment. Furthermore, as discussed above MW may also be 
measured more objectively using experience sampling 
methods in daily life or during experimental paradigms. 
Measures of MW may therefore assist in the accurate diag-
nosis of individuals based on their mental state rather than 
descriptions of behavior, which may be more subject to bias 
or influenced by an individual’s ability to develop compen-
satory behavioral strategies.
However, currently we do not know the role that exces-
sive MW, as measured by the MEWS, plays in other clinical 
disorders. For example, in depression depressive rumina-
tion represents another form of MW. Thus, the specificity of 
the MEWS across common mental health disorders needs 
to be explored. Therefore, we do not currently recommend 
the routine use of the MEWS to identify patients with 
ADHD until the scale has been comprehensively evaluated 
in other psychiatric disorders with overlapping clinical fea-
tures, although high MEWS scores could be used to support 
the diagnosis. Investigation of the role of excessive MW in 
childhood and early adolescent ADHD is also recom-
mended, including use of the scale in this population. 
Whether children and young adolescents would be able to 
conceptualize MW and reliably report on their mental state 
requires investigation.
Limitations and Future Research
Some participants in Study 2 presented with co-occurring 
anxiety and depression, raising the possibility that MW 
might be linked to comorbid conditions. However, in Study 
1 participants were free from co-occurring disorders 
(Skirrow & Asherson, 2013), yet similar results were found. 
Nevertheless, TUTs are a common feature of most mental 
health disorders and future research will need to investigate 
the distinction of excessive MW in ADHD from depressive 
ruminations, anxious worrying, and other sources of MW.
In relation to ADHD, a key question is whether MW dif-
fers conceptually from the inattentive symptoms currently 
used to define the disorder or whether the mental phenom-
enon of MW underlies the behavioral expression of inatten-
tion. As discussed above, it is feasible that measures of MW 
in ADHD are a more direct reflection of the neurobiology, 
leading to the inattentive symptoms of ADHD. Further 
work is required to evaluate the plausible hypothesis that 
aberrant regulation of DMN activity linked to excessive 
MW leads to ADHD symptoms and impairments. The study 
of MW has several potential advantages over behavioral 
inattention for research, because it may be measured using 
rating scales, as reported here, as well as experience sam-
pling during daily life (Killingsworth & Gilbert, 2010), or 
during sustained attention tasks (Shaw & Giambra, 1993) 
and neuroimaging studies (Baird, Smallwood, Lutz, & 
Schooler, 2014; Christoff, Gordon, Smallwood, Smith, & 
Schooler, 2009).
A fruitful next step in this research will be to take the 
MEWS into experimental paradigms. For example, an 
experimental trial of methylphenidate could be used to for-
mally evaluate whether improvements in MW mediate 
improvements in ADHD symptoms and impairments, and 
to investigate the underlying neural mechanisms. Yet, cur-
rently, there are very little data that link rating scale mea-
sures of MW to experimentally derived measures in ADHD. 
Validation of MW in ADHD is therefore required across the 
various levels of measurement (rating scale, experience 
sampling, and experimental paradigms including neuroim-
aging studies). We hypothesize that MW is a phenomenon 
that can be reliably measured, and it will be highly informa-
tive to see to what extent MEWS scores reflect TUTs mea-
sured during cognitive task performance in ADHD. It will 
also be advantageous to see how it relates to various cogni-
tive measures such as omission and commission errors 
(Losier, McGrath, & Klein, 1996), and RTV (Kofler et al., 
2013), which may reveal further information about the 
underlying neurobiology of ADHD.
Conclusion
This research provides further insight into the mental phe-
nomenon of MW in ADHD. We investigate a questionnaire-
based measure of excessive MW recently developed in our 
research group. The MEWS was found to be a valid and 
reliable measure, with comparable sensitivity and specific-
ity for case-control differences as existing rating scale mea-
sures of core ADHD symptoms currently used in clinical 
practice. The MEWS functioned extremely well for a brief 
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15-item measure and is potentially a useful measure to 
incorporate in future clinical and etiological research. 
MEWS scores were found to be a particularly good predic-
tor of impairment, highlighting the clinical utility of the tool 
for diagnosis and treatment. Based on these findings, there 
is strong premise to view MW as a common co-occurring 
feature of adult ADHD with a specific effect on impair-
ment, potentially explaining a variety of deficits not easily 
accounted for by the core symptom dimensions.
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